MediciNova Inc (MNOV)
2.13
+0.13
(+6.50%)
USD |
NASDAQ |
Nov 22, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
MediciNova Cash from Investing (Quarterly): -0.0009M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.0009M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.0027M |
| June 30, 2023 | -0.0186M |
| March 31, 2023 | 39.93M |
| December 31, 2022 | -30.00M |
| September 30, 2022 | -10.00M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0029M |
| June 30, 2021 | -0.0258M |
| March 31, 2021 | |
| December 31, 2020 | -0.0327M |
| September 30, 2020 | -0.0012M |
| June 30, 2020 | -0.00 |
| March 31, 2020 | -0.0026M |
| December 31, 2019 | -0.0073M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.0021M |
| March 31, 2019 | -0.002M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.6349M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.0086M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -0.0176M |
| September 30, 2016 | -0.0337M |
| June 30, 2016 | -0.0111M |
| March 31, 2016 | -0.022M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.0023M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.0035M |
| December 31, 2013 | -0.0122M |
| September 30, 2013 | 0.015M |
| June 30, 2013 | -0.0443M |
| March 31, 2013 | 0.0048M |
| December 31, 2012 | -0.0002M |
| September 30, 2012 | -0.0338M |
| June 30, 2012 | -0.0413M |
| March 31, 2012 | -0.688M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-30.00M
Minimum
Dec 2022
39.93M
Maximum
Mar 2023
-0.0095M
Average
-0.0019M
Median
Cash from Investing (Quarterly) Benchmarks
| BioVie Inc | 0.00 |
| BridgeBio Pharma Inc | 38.23M |
| Ikena Oncology Inc | 9.454M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.811M |
| Free Cash Flow | -8.553M |
| Free Cash Flow Per Share (Quarterly) | -0.0573 |
| Free Cash Flow Yield | -8.19% |